PNGAF (The Precision Peptide Co) EBITDA Margin %: -3,364.52% (As of Jan. 2026)


PNGAF The Precision Peptide Co Inc PNGAF
21 GF Score
Price $0.34
! 4 Warning Signs
View Full Analysis

What is The Precision Peptide Co EBITDA Margin %?

The Precision Peptide Co PNGAF -1.93% 21 EBITDA Margin % is -3,364.52% as of Jan. 2026. GuruFocus rates PNGAF with a GF Score™ of 21/100. The stock has 4 warning signs investors should review. Among 1,953 Consumer Packaged Goods companies, The Precision Peptide Co ranks worse than 99.54% on this metric.

EBITDA Margin % is calculated as EBITDA divided by its Revenue. The Precision Peptide Co's EBITDA for the three months ended in Jan. 2026 was $-1.04 Mil. The Precision Peptide Co's Revenue for the three months ended in Jan. 2026 was $0.03 Mil. Therefore, The Precision Peptide Co's EBITDA margin for the quarter that ended in Jan. 2026 was -3,364.52%.


The Precision Peptide Co  (OTCPK:PNGAF) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


The Precision Peptide Co EBITDA Margin % Related Terms


The Precision Peptide Co EBITDA Margin % Historical Data

* Premium members only.

The historical data trend for The Precision Peptide Co's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The Precision Peptide Co EBITDA Margin % Chart

The Precision Peptide Co Annual Data
Trend Oct21 Oct22 Oct23 Oct24 Oct25
EBITDA Margin %
0.00 -147.41 -559.81 -7,411.11 -4,291.67

The Precision Peptide Co Quarterly Data
Jul21 Oct21 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 -11,325.00 -2,487.10 -3,364.52

PNGAF vs KHC, GIS: EBITDA Margin % Comparison

For the Packaged Foods subindustry, The Precision Peptide Co's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


The Precision Peptide Co EBITDA Margin % vs Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, The Precision Peptide Co's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where The Precision Peptide Co's EBITDA Margin % falls into.


PNGAF
21GF Score
The Precision Peptide Co Inc PNGAF
EBITDA Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

The Precision Peptide Co EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

The Precision Peptide Co's EBITDA Margin % for the fiscal year that ended in Oct. 2025 is calculated as

EBITDA Margin %=EBITDA (A: Oct. 2025 )/Revenue (A: Oct. 2025 )
=-1.545/0.036
=-4,291.67 %

The Precision Peptide Co's EBITDA Margin % for the quarter that ended in Jan. 2026 is calculated as

EBITDA Margin %=EBITDA (Q: Jan. 2026 )/Revenue (Q: Jan. 2026 )
=-1.043/0.031
=-3,364.52 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBITDA Margin % →
What does a EBITDA Margin % of -3,364.52% mean?
The Precision Peptide Co (PNGAF) has a EBITDA Margin % of -3,364.52% as of Jan. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on The Precision Peptide Co and its competitors. According to the industry distribution chart, The Precision Peptide Co ranks #1944 out of 1953 companies in the Consumer Packaged Goods industry, placing it in the top 99.5%.
Is The Precision Peptide Co's EBITDA Margin % too high?
The Precision Peptide Co's current EBITDA Margin % is -3,364.52%. Based on the distribution chart, The Precision Peptide Co ranks #1944 out of 1953 companies in the Consumer Packaged Goods industry, which is in the bottom quartile relative to peers. Overall, The Precision Peptide Co has a GF Score™ of 21/100, reflecting its overall financial health beyond just this single metric.
How does The Precision Peptide Co's EBITDA Margin % compare to KHC and GIS?
According to the Consumer Packaged Goods industry distribution chart, The Precision Peptide Co ranks #1944 out of 1953 companies for EBITDA Margin %. This places The Precision Peptide Co in the lower half of its industry. The industry median EBITDA Margin % is 8.99. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Consumer Packaged Goods company?
The median EBITDA Margin % among Consumer Packaged Goods companies is 8.99, based on 1,953 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on The Precision Peptide Co and its competitors. For the Consumer Packaged Goods industry, the median EBITDA Margin % is 8.99 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. The Precision Peptide Co's current EBITDA Margin % is -3,364.52%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is The Precision Peptide Co stock overvalued right now?
The Precision Peptide Co (PNGAF) has a current EBITDA Margin % of -3,364.52%. The current EBITDA Margin % is -3,364.52%. The Precision Peptide Co's overall GF Score™ is 21/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For The Precision Peptide Co (PNGAF), the current EBITDA Margin % is -3,364.52% as of Jan. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

The Precision Peptide Co Business Description

Other Exchanges XU0:GermanyBPC:Canada
Address 130th Street, Suite 8035, Surrey, BC, CAN, V3W 0H7
The Precision Peptide Co Inc is a food manufacturer and distributor of nutritional supplements, functional snacks, natural foods, peptides, and natural personal care products. The company offers end-to-end services from formulation and ingredient sourcing to final packaging and fulfillment. The Company has two reportable operating segments: the manufacturing and distribution of food products in Canada and the sale and delivery of its peptide products in the United States.
21GF Score

Get the complete analysis for PNGAF

EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.34
Price